Drug Developed for Inherited Bleeding Disorder Shows Promising Trial Results

A study led by Mass General Brigham researchers found that engasertib lessened bleeding events for patients with HHT, the second most common inherited bleeding disorder.

Hereditary hemorrhagic telangiectasia (HHT) is the second most common…